Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All acetaminophen studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchAcetaminophenAcetaminophen (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Association Between Nonsteroidal Antiinflammatory Drug Use and Adverse Clinical Outcomes Among Adults Hospitalized With Coronavirus 2019 in South Korea: A Nationwide Study

Jeong et al., Clinical Infectious Diseases, doi:10.1093/cid/ciaa1056
Jul 2020  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Cardiovascular complicati.. -15% Improvement Relative Risk Renal failure -92% Acetaminophen  Jeong et al.  EARLY TREATMENT Is early treatment with acetaminophen beneficial for COVID-19? Retrospective study in South Korea (January - April 2020) Study compares with NSAIDs, results vs. placebo may differ No significant difference in outcomes seen c19early.org Jeong et al., Clinical Infectious Dise.., Jul 2020 Favorsacetaminophen FavorsNSAIDs 0 0.5 1 1.5 2+
1st treatment shown to increase risk in November 2020
 
*, now with p = 0.00000029 from 27 studies, but still recommended in 63 countries.
* From meta analysis with ≥3 studies.
4,300+ studies for 77 treatments. c19early.org
Retrospective 1,824 hospitalized COVID-19 patients in South Korea, showing higher progression to combined death, ICU, ventilation, or sepsis (4% versus 0%, group sizes not provided) with paracetamol vs. NSAIDs. Treatment time may vary - exposure was defined as 7 days before and including cohort entry in hospitalized COVID-19 patients.
Paracetamol is also known as acetaminophen, Tylenol, Panadol, Calpol, Tempra, Calprofen, Doliprane, Efferalgan, Grippostad C, Dolo, Acamol, Fevadol, Crocin, and Perfalgan.
risk of miscellaneous, 14.9% higher, OR 1.15, p = 0.61, inverted to make OR<1 favor treatment, cardiovascular complications, RR approximated with OR.
risk of miscellaneous, 92.3% higher, OR 1.92, p = 0.53, inverted to make OR<1 favor treatment, acute renal failure, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Jeong et al., 27 Jul 2020, retrospective, South Korea, peer-reviewed, 6 authors, study period 1 January, 2020 - 8 April, 2020, this trial compares with another treatment - results may be better when compared to placebo. Contact: shin.jy@skku.edu.
This PaperAcetaminophenAll
Association Between Nonsteroidal Antiinflammatory Drug Use and Adverse Clinical Outcomes Among Adults Hospitalized With Coronavirus 2019 in South Korea: A Nationwide Study
Han Eol Jeong, Hyesung Lee, Hyun Joon Shin, Young June Choe, Kristian B Filion, Ju-Young Shin
Clinical Infectious Diseases, doi:10.1093/cid/ciaa1056
Background. Nonsteroidal antiinflammatory drugs (NSAIDs) may exacerbate coronavirus disease 2019 (COVID-19) and worsen associated outcomes by upregulating the enzyme that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to in order to enter cells. Methods. We conducted a cohort study using South Korea's nationwide healthcare database, which contains data for all individuals who received a COVID-19 test (n = 69 793) as of 8 April 2020. We identified adults hospitalized with COVID-19, where cohort entry was the date of hospitalization. NSAID users were those prescribed NSAIDs in the 7 days before and including cohort entry, and nonusers were those not prescribed NSAIDs during this period. Our primary outcome was a composite of in-hospital death, intensive care unit admission, mechanical ventilation use, and sepsis; our secondary outcomes were cardiovascular complications and acute renal failure. We conducted logistic regression analysis to estimate odds ratio (OR) with 95% confidence intervals (CIs) using inverse probability of treatment weighting to minimize confounding. Results. Of 1824 adults hospitalized with COVID-19 (mean age, 49.0 years; female, 59%), 354 were NSAID users and 1470 were nonusers. Compared with nonuse, NSAID use was associated with increased risks of the primary composite outcome (OR, 1.54; 95% CI, 1.13-2.11) but insignificantly associated with cardiovascular complications (OR, 1.54; 95% CI, 0.96-2.48) or acute renal failure (OR, 1.45; 95% CI, 0.49-4.14). Conclusions. While awaiting the results of confirmatory studies, we suggest NSAIDs be used with caution for COVID-19 patients as the harms associated with their use may outweigh their benefits.
Supplementary Data Supplementary materials are available at Clinical Infectious Diseases online. Consisting of data provided by the authors to benefit the reader, the posted materials are not copyedited and are the sole responsibility of the authors, so questions or comments should be addressed to the corresponding author. Notes Author contributions. All authors contributed to the study design and interpretation of the data. H. E. J. and H. L. designed the study and interpreted the data. H. E. J. wrote the manuscript. H. L. conducted the statistical analyses. H. J. S., Y. J. C., and K. B. F. interpreted the data and critically revised the manuscript. All authors reviewed and commented on drafts, approved the final manuscript, and made the decision to submit it for publication. J-Y. S. is the guarantor. Acknowledgments. The authors thank healthcare professionals dedicated to treating coronavirus 2019 patients in South Korea, the Ministry of Health and Welfare, the Health Insurance Review & Assessment Service, and Do-Yeon Cho of the Health Insurance Review & Assessment Service of South Korea for sharing invaluable national health insurance claims data in a prompt manner. Disclaimer. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the manuscript. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication. Financial..
References
Bancos, Bernard, Topham, Phipps, Ibuprofen and other widely used non-steroidal anti-inflammatory drugs inhibit antibody production in human cells, Cell Immunol
Bhala, Emberson, Merhi, Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials, Lancet
Caughey, Cleland, Penglis, Gamble, James, Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2, J Immunol
Clavé, Rousset-Rouvière, Daniel, Tsimaratos, The invisible threat of non-steroidal anti-inflammatory drugs for kidneys, Front Pediatr
Desai, Franklin, Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners, BMJ
Fang, Karakiulakis, Roth, Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?, Lancet Respir Med
Fung, Yuen, Ye, Chan, Jin, A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses, Emerg Microbes Infect
Hoffmann, Kleine-Weber, Schroeder, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell
Huang, Zhang, Zhang, Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16-23 years outside Wuhan and characteristics of young patients with COVID-19: a prospective contact-tracing study, J Infect
Inaoka, Kimishima, Takahashi, Shiohara, Non-steroidal antiinflammatory drugs selectively inhibit cytokine production by NK cells and gamma delta T cells, Exp Dermatol
Kim, Yoon, Kim, Kim, Towards actualizing the value potential of Korea Health Insurance Review and Assessment (HIRA) Data as a resource for health research: strengths, limitations, applications, and strategies for optimal use of HIRA data, J Korean Med Sci
Kuba, Imai, Rao, A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury, Nat Med
Lee, Cheung, Nicholls, Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection, J Infect Dis
Li, Moore, Vasilieva, Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus, Nature
Little, Non-steroidal anti-inflammatory drugs and covid-19, BMJ, doi:10.1136/bmj.m1185
Moride, Abenhaim, Yola, Lucein, Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research, J Clin Epidemiol
Qiao, Wang, Chen, Ibuprofen attenuates cardiac fibrosis in streptozotocin-induced diabetic rats, Cardiology
Schmidt, Lamberts, Olsen, Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the Working Group for Cardiovascular Pharmacotherapy of the European Society of Cardiology, Eur Heart J
Suissa, Immortal time bias in pharmaco-epidemiology, Am J Epidemiol
Voiriot, Philippot, Elabbadi, Elbim, Chalumeau et al., Risks related to the use of non-steroidal anti-inflammatory drugs in communityacquired pneumonia in adult and pediatric patients, J Clin Med
Wen, Hsiao, Chan, Lin, Shen et al., Acute respiratory infection and use of nonsteroidal anti-inflammatory drugs on risk of acute myocardial infarction: a nationwide case-crossover study, J Infect Dis
Wen, Hsiao, Lin, Fang, Shen, Risk of stroke associated with use of nonsteroidal anti-inflammatory drugs during acute respiratory infection episode, Pharmacoepidemiol Drug Saf
Zhang, Donnan, Bell, Guthrie, Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis, BMC Nephrol
{ 'indexed': {'date-parts': [[2022, 8, 26]], 'date-time': '2022-08-26T15:51:11Z', 'timestamp': 1661529071720}, 'reference-count': 35, 'publisher': 'Oxford University Press (OUP)', 'issue': '11', 'license': [ { 'start': { 'date-parts': [[2020, 7, 27]], 'date-time': '2020-07-27T00:00:00Z', 'timestamp': 1595808000000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model'}], 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2021, 12, 6]]}, 'abstract': '<jats:title>Abstract</jats:title>\n' ' <jats:sec>\n' ' <jats:title>Background</jats:title>\n' ' <jats:p>Nonsteroidal antiinflammatory drugs (NSAIDs) may exacerbate ' 'coronavirus disease 2019 (COVID-19) and worsen associated outcomes by upregulating the enzyme ' 'that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to in order to enter ' 'cells.</jats:p>\n' ' </jats:sec>\n' ' <jats:sec>\n' ' <jats:title>Methods</jats:title>\n' ' <jats:p>We conducted a cohort study using South Korea’s nationwide ' 'healthcare database, which contains data for all individuals who received a COVID-19 test (n ' '= 69 793) as of 8 April 2020. We identified adults hospitalized with COVID-19, where cohort ' 'entry was the date of hospitalization. NSAID users were those prescribed NSAIDs in the 7 days ' 'before and including cohort entry, and nonusers were those not prescribed NSAIDs during this ' 'period. Our primary outcome was a composite of in-hospital death, intensive care unit ' 'admission, mechanical ventilation use, and sepsis; our secondary outcomes were cardiovascular ' 'complications and acute renal failure. We conducted logistic regression analysis to estimate ' 'odds ratio (OR) with 95% confidence intervals (CIs) using inverse probability of treatment ' 'weighting to minimize confounding.</jats:p>\n' ' </jats:sec>\n' ' <jats:sec>\n' ' <jats:title>Results</jats:title>\n' ' <jats:p>Of 1824 adults hospitalized with COVID-19 (mean age, 49.0 years; ' 'female, 59%), 354 were NSAID users and 1470 were nonusers. Compared with nonuse, NSAID use ' 'was associated with increased risks of the primary composite outcome (OR, 1.54; 95% CI, ' '1.13–2.11) but insignificantly associated with cardiovascular complications (OR, 1.54; 95% ' 'CI, 0.96–2.48) or acute renal failure (OR, 1.45; 95% CI, 0.49–4.14).</jats:p>\n' ' </jats:sec>\n' ' <jats:sec>\n' ' <jats:title>Conclusions</jats:title>\n' ' <jats:p>While awaiting the results of confirmatory studies, we suggest ' 'NSAIDs be used with caution for COVID-19 patients as the harms associated with their use may ' 'outweigh their benefits.</jats:p>\n' ' </jats:sec>', 'DOI': '10.1093/cid/ciaa1056', 'type': 'journal-article', 'created': {'date-parts': [[2020, 7, 22]], 'date-time': '2020-07-22T19:22:47Z', 'timestamp': 1595445767000}, 'page': 'e4179-e4188', 'source': 'Crossref', 'is-referenced-by-count': 10, 'title': 'Association Between Nonsteroidal Antiinflammatory Drug Use and Adverse Clinical Outcomes Among ' 'Adults Hospitalized With Coronavirus 2019 in South Korea: A Nationwide Study', 'prefix': '10.1093', 'volume': '73', 'author': [ { 'given': 'Han Eol', 'family': 'Jeong', 'sequence': 'first', 'affiliation': [ { 'name': 'Department of Clinical and Social Pharmacy, School of Pharmacy, ' 'Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea'}]}, { 'given': 'Hyesung', 'family': 'Lee', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Clinical and Social Pharmacy, School of Pharmacy, ' 'Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea'}]}, { 'given': 'Hyun Joon', 'family': 'Shin', 'sequence': 'additional', 'affiliation': [ { 'name': 'Division of General Internal Medicine, Department of Medicine, ' 'Brigham and Women’s Hospital, and Department of Global Health ' 'and Social Medicine, Harvard Medical School, Boston, ' 'Massachusetts, USA'}]}, { 'given': 'Young June', 'family': 'Choe', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Social and Preventive Medicine, Hallym University ' 'College of Medicine, Chuncheon, Gangwon-do, South Korea'}]}, { 'given': 'Kristian B', 'family': 'Filion', 'sequence': 'additional', 'affiliation': [ { 'name': 'Departments of Medicine and of Epidemiology, Biostatistics and ' 'Occupational Health, McGill University, Montreal, Quebec, ' 'Canada'}, { 'name': 'Centre for Clinical Epidemiology, Lady Davis Institute, ' 'Montreal, Quebec, Canada'}]}, { 'ORCID': 'http://orcid.org/0000-0003-1010-7525', 'authenticated-orcid': False, 'given': 'Ju-Young', 'family': 'Shin', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Clinical and Social Pharmacy, School of Pharmacy, ' 'Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea'}, { 'name': 'Department of Clinical Research Design and Evaluation, Samsung ' 'Advanced Institute for Health Sciences & Technology, ' 'Sungkyunkwan University, Seoul, South Korea'}]}], 'member': '286', 'published-online': {'date-parts': [[2020, 7, 27]]}, 'reference': [ {'key': '2021121011170977900_CIT0001', 'author': 'World Health Organization'}, { 'key': '2021121011170977900_CIT0002', 'doi-asserted-by': 'crossref', 'first-page': 'e1', 'DOI': '10.1016/j.jinf.2020.03.006', 'article-title': 'Rapid asymptomatic transmission of COVID-19 during the incubation ' 'period demonstrating strong infectivity in a cluster of youngsters aged ' '16–23 years outside Wuhan and characteristics of young patients with ' 'COVID-19: a prospective contact-tracing study', 'volume': '80', 'author': 'Huang', 'year': '2020', 'journal-title': 'J Infect'}, { 'key': '2021121011170977900_CIT0003', 'doi-asserted-by': 'crossref', 'first-page': 'e21', 'DOI': '10.1016/S2213-2600(20)30116-8', 'article-title': 'Are patients with hypertension and diabetes mellitus at increased risk ' 'for COVID-19 infection?', 'volume': '8', 'author': 'Fang', 'year': '2020', 'journal-title': 'Lancet Respir Med'}, { 'key': '2021121011170977900_CIT0004', 'doi-asserted-by': 'crossref', 'first-page': '271', 'DOI': '10.1016/j.cell.2020.02.052', 'article-title': 'SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a ' 'clinically proven protease inhibitor', 'volume': '181', 'author': 'Hoffmann', 'year': '2020', 'journal-title': 'Cell'}, { 'key': '2021121011170977900_CIT0005', 'doi-asserted-by': 'crossref', 'first-page': '2831', 'DOI': '10.4049/jimmunol.167.5.2831', 'article-title': 'Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by ' 'human endothelial cells: selective up-regulation of prostacyclin ' 'synthesis by COX-2', 'volume': '167', 'author': 'Caughey', 'year': '2001', 'journal-title': 'J Immunol'}, { 'key': '2021121011170977900_CIT0006', 'doi-asserted-by': 'crossref', 'first-page': '525', 'DOI': '10.1086/590499', 'article-title': 'Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a ' 'mechanism for the pathogenesis of avian influenza H5N1 infection', 'volume': '198', 'author': 'Lee', 'year': '2008', 'journal-title': 'J Infect Dis'}, { 'key': '2021121011170977900_CIT0007', 'doi-asserted-by': 'crossref', 'first-page': '558', 'DOI': '10.1080/22221751.2020.1736644', 'article-title': 'A tug-of-war between severe acute respiratory syndrome coronavirus 2 ' 'and host antiviral defence: lessons from other pathogenic viruses', 'volume': '9', 'author': 'Fung', 'year': '2020', 'journal-title': 'Emerg Microbes Infect'}, { 'key': '2021121011170977900_CIT0008', 'volume-title': 'Update–Coronavirus: French health minister and WHO issue warning over ' 'taking anti-inflammatories', 'author': 'Emma', 'year': '2020'}, { 'key': '2021121011170977900_CIT0009', 'volume-title': 'FDA advises patients on use of non-steroidal anti-inflammatory drugs ' '(NSAIDs) for COVID-19', 'author': 'US Food and Drug Administration', 'year': '2020'}, { 'key': '2021121011170977900_CIT0010', 'volume-title': 'EMA gives advice on the use of non-steroidal anti-inflammatories for ' 'COVID-19', 'author': 'European Medicines Agency', 'year': '2020'}, { 'key': '2021121011170977900_CIT0011', 'volume-title': 'No evidence to support claims ibuprofen worsens COVID-19 symptoms', 'author': 'Therapeutic Goods Administration', 'year': '2020'}, { 'key': '2021121011170977900_CIT0012', 'volume-title': 'Scientific Brief: The use of non-steroidal anti-inflammatory drugs ' '(NSAIDs) in patients with COVID-19', 'author': 'World Health Organization', 'year': '2020'}, {'key': '2021121011170977900_CIT0013'}, { 'key': '2021121011170977900_CIT0014', 'doi-asserted-by': 'crossref', 'first-page': '718', 'DOI': '10.3346/jkms.2017.32.5.718', 'article-title': 'Towards actualizing the value potential of Korea Health Insurance ' 'Review and Assessment (HIRA) Data as a resource for health research: ' 'strengths, limitations, applications, and strategies for optimal use of ' 'HIRA data', 'volume': '32', 'author': 'Kim', 'year': '2017', 'journal-title': 'J Korean Med Sci'}, { 'key': '2021121011170977900_CIT0015', 'volume-title': 'Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected ' 'human cases: interim guidance', 'author': 'World Health Organization', 'year': '2020'}, {'key': '2021121011170977900_CIT0016', 'author': 'Ministry of Health and Welfare RoK'}, { 'key': '2021121011170977900_CIT0017', 'doi-asserted-by': 'crossref', 'first-page': '492', 'DOI': '10.1093/aje/kwm324', 'article-title': 'Immortal time bias in pharmaco-epidemiology', 'volume': '167', 'author': 'Suissa', 'year': '2008', 'journal-title': 'Am J Epidemiol'}, { 'key': '2021121011170977900_CIT0018', 'doi-asserted-by': 'crossref', 'first-page': 'l5657', 'DOI': '10.1136/bmj.l5657', 'article-title': 'Alternative approaches for confounding adjustment in observational ' 'studies using weighting based on the propensity score: a primer for ' 'practitioners', 'volume': '367', 'author': 'Desai', 'year': '2019', 'journal-title': 'BMJ'}, { 'key': '2021121011170977900_CIT0019', 'article-title': 'Reducing bias in a propensity score matched-pair sample using greedy ' 'matching techniques.', 'volume-title': 'Proceedings of the Twenty-sixth Annual SAS Users Group International ' 'Conference', 'year': '2001'}, { 'key': '2021121011170977900_CIT0020', 'volume-title': 'Anti-inflammatoires non steroidiens (AINS) et complications infectieuses ' 'graves - Point d’Information', 'author': 'L’Agence nationale de securite du medicament et des produits de sante (ANSM)', 'year': '2019'}, { 'key': '2021121011170977900_CIT0021', 'doi-asserted-by': 'crossref', 'first-page': '786', 'DOI': '10.3390/jcm8060786', 'article-title': 'Risks related to the use of non-steroidal anti-inflammatory drugs in ' 'community-acquired pneumonia in adult and pediatric patients', 'volume': '8', 'author': 'Voiriot', 'year': '2019', 'journal-title': 'J Clin Med'}, { 'key': '2021121011170977900_CIT0022', 'doi-asserted-by': 'crossref', 'article-title': 'Non-steroidal anti-inflammatory drugs and covid-19', 'author': 'Little', 'year': '2020', 'journal-title': 'BMJ', 'DOI': '10.1136/bmj.m1185'}, { 'key': '2021121011170977900_CIT0023', 'doi-asserted-by': 'crossref', 'first-page': '503', 'DOI': '10.1093/infdis/jiw603', 'article-title': 'Acute respiratory infection and use of nonsteroidal anti-inflammatory ' 'drugs on risk of acute myocardial infarction: a nationwide ' 'case-crossover study', 'volume': '215', 'author': 'Wen', 'year': '2017', 'journal-title': 'J Infect Dis'}, { 'key': '2021121011170977900_CIT0024', 'doi-asserted-by': 'crossref', 'first-page': '645', 'DOI': '10.1002/pds.4428', 'article-title': 'Risk of stroke associated with use of nonsteroidal anti-inflammatory ' 'drugs during acute respiratory infection episode', 'volume': '27', 'author': 'Wen', 'year': '2018', 'journal-title': 'Pharmacoepidemiol Drug Saf'}, { 'key': '2021121011170977900_CIT0025', 'doi-asserted-by': 'crossref', 'first-page': '1015', 'DOI': '10.1093/eurheartj/ehv505', 'article-title': 'Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory ' 'drugs: review and position paper by the Working Group for ' 'Cardiovascular Pharmacotherapy of the European Society of Cardiology', 'volume': '37', 'author': 'Schmidt', 'year': '2016', 'journal-title': 'Eur Heart J'}, { 'key': '2021121011170977900_CIT0026', 'doi-asserted-by': 'crossref', 'first-page': '769', 'DOI': '10.1016/S0140-6736(13)60900-9', 'article-title': 'Vascular and upper gastrointestinal effects of non-steroidal ' 'anti-inflammatory drugs: meta-analyses of individual participant data ' 'from randomised trials', 'volume': '382', 'author': 'Bhala', 'year': '2013', 'journal-title': 'Lancet'}, { 'key': '2021121011170977900_CIT0027', 'doi-asserted-by': 'crossref', 'first-page': '520', 'DOI': '10.3389/fped.2019.00520', 'article-title': 'The invisible threat of non-steroidal anti-inflammatory drugs for ' 'kidneys', 'volume': '7', 'author': 'Clavé', 'year': '2017', 'journal-title': 'Front Pediatr'}, { 'key': '2021121011170977900_CIT0028', 'doi-asserted-by': 'crossref', 'first-page': '256', 'DOI': '10.1186/s12882-017-0673-8', 'article-title': 'Non-steroidal anti-inflammatory drug induced acute kidney injury in the ' 'community dwelling general population and people with chronic kidney ' 'disease: systematic review and meta-analysis', 'volume': '18', 'author': 'Zhang', 'year': '2017', 'journal-title': 'BMC Nephrol'}, { 'key': '2021121011170977900_CIT0029', 'doi-asserted-by': 'crossref', 'first-page': '97', 'DOI': '10.1159/000375362', 'article-title': 'Ibuprofen attenuates cardiac fibrosis in streptozotocin-induced ' 'diabetic rats', 'volume': '131', 'author': 'Qiao', 'year': '2015', 'journal-title': 'Cardiology'}, { 'key': '2021121011170977900_CIT0030', 'doi-asserted-by': 'crossref', 'first-page': '450', 'DOI': '10.1038/nature02145', 'article-title': 'Angiotensin-converting enzyme 2 is a functional receptor for the SARS ' 'coronavirus', 'volume': '426', 'author': 'Li', 'year': '2003', 'journal-title': 'Nature'}, { 'key': '2021121011170977900_CIT0031', 'doi-asserted-by': 'crossref', 'first-page': '875', 'DOI': '10.1038/nm1267', 'article-title': 'A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS ' 'coronavirus-induced lung injury', 'volume': '11', 'author': 'Kuba', 'year': '2005', 'journal-title': 'Nat Med'}, { 'key': '2021121011170977900_CIT0032', 'doi-asserted-by': 'crossref', 'first-page': '18', 'DOI': '10.1016/j.cellimm.2009.03.007', 'article-title': 'Ibuprofen and other widely used non-steroidal anti-inflammatory drugs ' 'inhibit antibody production in human cells', 'volume': '258', 'author': 'Bancos', 'year': '2009', 'journal-title': 'Cell Immunol'}, { 'key': '2021121011170977900_CIT0033', 'doi-asserted-by': 'crossref', 'first-page': '981', 'DOI': '10.1111/j.1600-0625.2006.00505.x', 'article-title': 'Non-steroidal anti-inflammatory drugs selectively inhibit cytokine ' 'production by NK cells and gamma delta T cells', 'volume': '15', 'author': 'Inaoka', 'year': '2006', 'journal-title': 'Exp Dermatol'}, { 'key': '2021121011170977900_CIT0034', 'volume-title': 'Evaluation and consideration methods of consistency between health ' 'insurance claims diagnostic codes and medical records', 'author': 'Health Insurance Review and Assessment Service', 'year': '2017'}, { 'key': '2021121011170977900_CIT0035', 'doi-asserted-by': 'crossref', 'first-page': '731', 'DOI': '10.1016/0895-4356(94)90170-8', 'article-title': 'Evidence of the depletion of susceptibles effect in non-experimental ' 'pharmacoepidemiologic research', 'volume': '47', 'author': 'Moride', 'year': '1994', 'journal-title': 'J Clin Epidemiol'}], 'container-title': 'Clinical Infectious Diseases', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'http://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciaa1056/33787343/ciaa1056.pdf', 'content-type': 'application/pdf', 'content-version': 'am', 'intended-application': 'syndication'}, { 'URL': 'https://academic.oup.com/cid/article-pdf/73/11/e4179/41608032/ciaa1056.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'syndication'}, { 'URL': 'https://academic.oup.com/cid/article-pdf/73/11/e4179/41608032/ciaa1056.pdf', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2021, 12, 10]], 'date-time': '2021-12-10T11:31:01Z', 'timestamp': 1639135861000}, 'score': 1, 'resource': {'primary': {'URL': 'https://academic.oup.com/cid/article/73/11/e4179/5876905'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2020, 7, 27]]}, 'references-count': 35, 'journal-issue': { 'issue': '11', 'published-online': {'date-parts': [[2020, 7, 27]]}, 'published-print': {'date-parts': [[2021, 12, 6]]}}, 'URL': 'http://dx.doi.org/10.1093/cid/ciaa1056', 'relation': {}, 'ISSN': ['1058-4838', '1537-6591'], 'subject': ['Infectious Diseases', 'Microbiology (medical)'], 'published-other': {'date-parts': [[2021, 12, 1]]}, 'published': {'date-parts': [[2020, 7, 27]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit